Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

PEARRL

Financiado

Cerrado

Pharmaceutical Education And Research with Regulatory Links Innovative drug dev...

Pharmaceutical Education And Research with Regulatory Links Innovative drug development strategies and regulatory tools tailored to facilitate earlier access to medicines The European Pharma industry is a major contributor to EU well-being, both in public health and economic (sales >200 billion €/year) terms. To maintain global leadership, it must respond to challenges from low-cost producers e.g.... ver más

31/08/2020

UCC

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

UNIVERSITY COLLEGE CORK NATIONAL UNIVERSITY... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 10 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2020-08-31

MSCA-ITN-2015-ETN: Marie Skłodowska-Curie Innovative T...

I+D

Cerrada hace 10 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

10 Participantes

UCC

531.35K€ | Lider

JANSSEN PHARMACEUTICA NV

250.56K€ | Participante

UBAH

546.58K€ | Participante

UOA

484.77K€ | Participante

Proyectos interesantes

SAFESCIMET

Medical Technol...

Data Science

6M€ Cerrado

SAFESCIMET

Medical Technol...

Data Science

6M€ Cerrado

ERAMET

Medical Technol...

Data Science

4M€ Cerrado

FutForm

Medical Technol...

Data Science

414K€ Cerrado

More-EUROPA

Medical Technol...

Data Science

7M€ Cerrado

START-UP

Medical Technol...

Data Science

356K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 54 meses Fecha Inicio: 2016-02-12
Fecha Fin: 2020-08-31

Líder del proyecto

UNIVERSITY COLLEGE CORK NATIONAL UNIVERSITY... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 4M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The European Pharma industry is a major contributor to EU well-being, both in public health and economic (sales >200 billion €/year) terms. To maintain global leadership, it must respond to challenges from low-cost producers e.g. China by bringing new drug molecules to market in a streamlined, cost-effective manner. This strategy is underscored by recent initiatives of European regulators to expedite the approval of breakthrough drugs so patients can gain earlier access to life-saving drugs. To realise these goals, scientists with an integral understanding of drug development and regulatory approval processes are urgently needed. PEARRL will train 15 Early Stage Researchers (ESR) who can develop new bio-enabling formulations (better drugs), biorelevant and in silico methods to predict formulation performance in vivo (streamlined development) and serve as communication bridgers between research and regulatory science (accelerated approval), thus bringing Pharma and regulatory objectives to fruition. PEARRL brings a multi-sectorial team, comprising key European regulatory authorities, academic leaders in bio-enabling formulations and biopharmaceutics tools, and an array of Pharma companies with a wealth of combined experience in bringing molecules to market, together for the first time to deliver a unique research and training programme. Key PEARRL elements are individual research projects with synergistic output; exposure of all ESR to academia, industry and regulatory in secondments; and ongoing innovative learning via Online Portals, Science Slams and Boot Camps. Key PEARRL impacts will be availability of excellent pharmaceutical researchers; streamlined drug development with a higher success rate for the industrial partners; enriched academic research through cooperation with industry and regulatory; earlier availability of breakthrough medicines to patients; a competitive pharma industry in Europe and contributions to European public health interests.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores